Petros Pharmaceuticals
PTPI
#10569
Rank
โ‚น30.49 M
Marketcap
โ‚น0.72
Share price
33.33%
Change (1 day)
-99.91%
Change (1 year)

Revenue for Petros Pharmaceuticals (PTPI)

Revenue in 2025 (TTM): โ‚น62.22 Million

According to Petros Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น65.25 Million. In 2024 the company made a revenue of โ‚น62.22 Million a decrease over the revenue in the year 2023 that were of โ‚น0.48 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Petros Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น62.22 M0%
2024 โ‚น62.22 M-87.16%
2023 โ‚น0.48 B-2.25%
2022 โ‚น0.49 B-14.72%
2021 โ‚น0.58 B-16.84%
2020 โ‚น0.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.51 B 19,075.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas